Related Experiment Video
Updated: Dec 31, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
An Efficient, Lung-Targeted, Drug-Delivery System To Treat Asthma Via Microparticles
Nagaraja SreeHarsha1,2, Katharigatta N Venugopala1,3, Anroop B Nair1
1Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
This study demonstrates that salbutamol-loaded microspheres offer an effective lung-targeted drug delivery system for asthma treatment, improving drug concentration and efficacy compared to conventional methods.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Respiratory Medicine
Background:
- Chronic diseases, including asthma, are leading causes of death in developing nations.
- Conventional asthma treatments often result in ineffective drug delivery to the lungs and undesirable side effects.
- Microspheres present a promising alternative for targeted drug delivery in respiratory conditions.
Purpose of the Study:
- To develop and optimize a salbutamol-loaded poly lactic acid-co-glycolic acid-polyethylene glycol (PLGA-PEG) microsphere formulation for enhanced lung delivery.
- To evaluate the efficacy and safety of this novel microsphere-based drug delivery system for asthma treatment.
Main Methods:
- Salbutamol-loaded PLGA-PEG microspheres were prepared using a nanospray drier.
- Face-centered central composite design (CCD) was employed to optimize the spray-drying process parameters.
- In vitro drug release, particle size analysis, in vivo efficacy studies in rabbits, stability testing, and cytotoxicity assays on A549 cell lines were conducted.
Main Results:
- The optimized microsphere formulation achieved a drug content of 72%±0.8% and a product yield of 86%±0.4%.
- In vitro drug release reached 91.1% over 12 hours. The particle size was determined to be 8.24 µm.
- In vivo studies showed significantly higher drug concentration and targeting efficacy in the lungs with the microsphere formulation (1,410.1±10.11 µg/g at 15 min) compared to conventional methods (92±0.56 µg/g at 10 min).
- The microspheres demonstrated good stability and a favorable safety profile.
Conclusions:
- Salbutamol-loaded PLGA-PEG microspheres represent a viable and effective alternative for lung-targeted asthma therapy.
- This novel drug delivery system enhances drug concentration in the lungs, potentially improving treatment outcomes for asthma patients.
- The developed microspheres offer a safe and stable option for public health interventions in managing chronic respiratory diseases.
Related Concept Videos
Inhaled Medications
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

